Similar Items: Suicide adverse events associated with zopiclone and eszopiclone: A pharmacovigilance analysis based on FAERS, JADER and CVARD
- Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER
- Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)
- Association between event-related disclosure and posttraumatic growth: Targeting Japanese people, measuring attitudes toward disclosure, and examining event-related rumination as a mediating variable
- Inside the world of non-suicidal self-injury e-communities: Language, identity and need for belonging
- Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system
- Mitogenomes reveal the timing and distribution of divergence events among trans-Beringian birds